Pure acetylsalicylic acid, the compound most people know as aspirin, melts at roughly 135 °C to 140 °C, though the exact number you encounter depends on who measured it and how. Manufacturers typically list the melting range at 134 °C to 136 °C, while laboratory instruments that measure heat flow during warming often report the onset of melting a few degrees higher. That spread is not a mistake or a sign of impure samples; it reflects genuine complexity in the way aspirin behaves as it heats up, from the crystal form sitting in the sample pan to the speed at which the temperature rises.
Why Published Melting Points for Aspirin Vary by Several Degrees
Open a pharmaceutical reference and you might see 135 °C. Run your own thermal analysis and the instrument could spit out something closer to 138 °C or even 141 °C. One manufacturer lists the melting range as 134 °C to 136 °C, a window that pharmacopeias have used for decades as a quick purity check.
When researchers use differential scanning calorimetry, which tracks the heat a sample absorbs as it warms, the numbers tend to shift upward. One such investigation of the pure compound reported an extrapolated melting onset of 138.5 °C and a melting enthalpy of 178 J/g, while also noting that actual softening began at temperatures “significantly lower” than that onset value.1NETZSCH Analyzing & Testing. About the Thermal Behavior of Acetylsalicylic Acid and Aspirin Another thermal study placed the melting point at about 409 K, or around 136 °C.2Acta Physico-Chimica Sinica. Studies on Thermal Decomposition Mechanism and Kinetics of Aspirin A more recent characterization of crystalline acetylsalicylic acid put the figure at 140.8 °C.3PubMed Central. Thermodynamic and Structural Characterization of a Mechanochemically Synthesized Pyrazinamide–Acetylsalicylic–Acid Eutectic Mixture
The differences come down to method. A traditional capillary melting-point apparatus, the kind still used in teaching labs, records the temperature at which a researcher’s eye sees the powder collapse into liquid. That visual judgment tends to catch the early edge of the melting range. Calorimetric instruments, by contrast, define “melting point” through a mathematical construction called the extrapolated onset, which is the temperature at which the steepest part of the melting curve, projected backward, meets the baseline. That mathematical construction almost always lands a few degrees above the moment the first crystals actually start to give way. Neither number is wrong; they just answer slightly different questions about the same physical event.
Aspirin Starts Decomposing Almost as Soon as It Melts
What makes aspirin’s melting behavior especially tricky is that the compound does not sit around as a stable liquid for long. As the temperature climbs past the melting range, the molecule begins to break apart. Thermogravimetric studies show two distinct stages of mass loss: first, the release of salicylic acid and acetic acid, with an intermediate compound forming, and then the further breakdown of that intermediate.4Thermochimica Acta. An investigation about the solid state thermal degradation of acetylsalicylic acid: polymer formation The first breakdown is essentially the reverse of aspirin’s original synthesis: the acetyl group peels away, regenerating the salicylic acid that aspirin was designed to improve upon.
Because decomposition begins so close to the melting temperature, researchers who heat their samples quickly sometimes capture a “clean” melting peak before degradation muddies the picture. Those who heat slowly may find that by the time all the crystals have melted, some of the liquid is already something other than aspirin. This overlap between melting and decomposition is a major reason the reported enthalpy of fusion, the energy absorbed during melting, varies across the literature. One group reports roughly 29 kJ per mole, another about 41 kJ per mole, and a third expresses it as 178 J per gram.2Acta Physico-Chimica Sinica. Studies on Thermal Decomposition Mechanism and Kinetics of Aspirin3PubMed Central. Thermodynamic and Structural Characterization of a Mechanochemically Synthesized Pyrazinamide–Acetylsalicylic–Acid Eutectic Mixture Differences in heating rate, atmosphere, and sample handling all feed into those discrepancies. The practical takeaway is that aspirin’s melting point is close to its decomposition point, so any experiment that involves heating the compound needs to move quickly or accept that the melt will be partly degraded.
Crystal Forms and Why They Matter
Aspirin has more than one way of arranging its molecules in a crystal. The two best-characterized arrangements are called Form I and Form II. Both are built from pairs of aspirin molecules (dimers) stacked in layers, but the layers align differently. In Form I, alternating dimer layers repeat in a regular pattern. In Form II, those layers are shifted sideways relative to one another, like a deck of cards nudged out of alignment.5ACS Omega. Revisiting Aspirin Polymorphic Stability Using a Machine Learning Potential
That seemingly minor structural difference has thermodynamic consequences. Computational simulations using a machine-learning-trained model found that Form I sits at a lower free energy than Form II across the entire range from 0 to 400 K, meaning Form I is the more stable polymorph at all practical temperatures.6PubMed Central. Revisiting Aspirin Polymorphic Stability Using a Machine Learning Potential Form II is not wildly unstable, though. The energy gap between the two forms is small enough that Form II can persist for extended periods, and it has been observed in real crystals, not just simulations. Because the two forms pack molecules at slightly different densities, they respond to heat differently, expanding at different rates as temperature rises. In principle the two forms could also show slightly different melting points, although the gap is expected to be very small given how close they are in energy.
For most people, the polymorphism question is academic. The aspirin in a bottle of tablets is overwhelmingly Form I, the thermodynamically favored arrangement. But for pharmaceutical manufacturers and crystal engineers, controlling which form crystallizes out of solution matters for everything from how easily a tablet compresses to how fast it dissolves in the stomach.
What Happens When You Shrink Aspirin Crystals to Nanoscale
One of the more striking findings in recent aspirin research involves nanocrystals. When aspirin particles are milled down from their usual size of a few micrometers to around 150 to 200 nanometers, the melting point drops dramatically. Nano-aspirin produced using cyclohexane as a milling medium showed a melting point of about 119 °C, and particles prepared with water melted at roughly 114 °C.7RSC Mechanochemistry. Mechanochemical synthesis of aspirin nanocrystals for pharmaceutical applications That is a depression of 15 to 25 degrees compared to bulk aspirin.
The phenomenon behind this is well established in materials science. As a crystal gets smaller, its surface area relative to its volume increases sharply. Atoms or molecules on the surface are less tightly bound than those buried in the interior, so a smaller crystal requires less energy to disrupt its lattice and begin melting. This effect is negligible in ordinary-sized pharmaceutical crystals but becomes substantial once particles drop below about a micrometer.
The interest in nano-aspirin is not purely academic. Smaller particles dissolve faster, which could mean faster onset of pain relief. If the crystals are small enough to lower the melting point significantly, they may also change the way aspirin interacts with other components in a tablet during manufacturing, for instance during processes that involve mild heating or compression. The trade-off is stability: those same high-energy surfaces that lower the melting point also make nanocrystals more prone to recrystallizing back into larger, more thermodynamically comfortable particles over time.
Aspirin’s Unusual Glassy State
Most people think of aspirin as a white crystalline powder, but it can also exist as a glass, a solid with the disordered molecular arrangement of a liquid. Researchers have made glassy aspirin by melting it and cooling the liquid quickly enough to prevent the molecules from reorganizing into crystals. Remarkably, that supercooled liquid turned out to be stable against crystallization for several days at room temperature, even when seed crystals were present.8Physical Chemistry Chemical Physics. On the glassy and supercooled liquid states of a common medicament: Aspirin
The glass-softening temperature of aspirin, the point at which the rigid glass starts to become a rubbery, mobile solid, was measured at about 244 K, or roughly −29 °C.8Physical Chemistry Chemical Physics. On the glassy and supercooled liquid states of a common medicament: Aspirin Below that temperature the glassy form is essentially frozen in place. Above it, molecules begin to shift around, a process called structural relaxation. Ball-milling crystalline aspirin at room temperature can also partially convert it to the glassy form, which means vigorous mechanical processing during manufacturing could unintentionally produce some amorphous material.
Why does any of this matter? Amorphous drugs often dissolve faster than their crystalline counterparts because there is no crystal lattice to disassemble first. But the amorphous form is also less stable. Over time it tends to revert to the crystal, and the rate at which that reversion happens depends heavily on storage temperature and humidity. For aspirin specifically, the fact that the supercooled liquid resists crystallization for days is unusual and has drawn attention from researchers interested in the physics of glass formation.
How Storage Affects the Compound Before You Ever Heat It
The melting point you measure depends on what is actually in the sample, and aspirin has a well-known weakness: moisture. When exposed to humid air, the ester bond in the molecule hydrolyzes, producing salicylic acid and acetic acid. That is the same reaction that happens at high temperature, just running slowly at room temperature whenever water is available.9Journal of Pharmaceutical Research International. Stability Evaluation of Acetylsalicylic Acid in Commercial Aspirin Tablets under Different Storage Conditions
If you have ever opened an old bottle of aspirin and noticed a vinegar-like smell, that is acetic acid, the telltale sign that hydrolysis has been at work. The salicylic acid left behind is itself a crystalline solid with a melting point around 159 °C. A partially degraded sample is therefore a mixture: some intact aspirin and some salicylic acid. When you heat that mixture, it melts over a broader and messier range than pure aspirin would, often starting lower because the two compounds form a eutectic mixture that depresses the melting point below either pure component’s value.
This is precisely why melting point determination is still used as a purity check for aspirin, even in an era of sophisticated analytical instruments. A sharp melting range close to the expected 135–136 °C suggests a clean sample. A broad, depressed melting range is a red flag for degradation. Pharmacy students learn this as one of their first practical exercises, and it remains a useful, cheap, and rapid quality indicator.
Mixing Aspirin with Other Drugs Changes the Melting Behavior
Pharmaceutical scientists sometimes deliberately combine aspirin with a second compound to form a eutectic mixture, a composition that melts at a temperature lower than either ingredient on its own. An aspirin–paracetamol eutectic, for instance, has been investigated for its mechanical and thermal properties.10CrystEngComm. Implication of microstructure on the mechanical behaviour of an aspirin–paracetamol eutectic mixture The motivation is usually practical: controlling how a combined tablet compresses, how quickly it disintegrates, or how easily it processes through manufacturing equipment.
A similar approach involves cocrystals, where two molecules crystallize together in a single ordered lattice rather than simply forming a physical mixture. Cocrystals of aspirin with other active ingredients or with inert “coformers” can shift the melting point, alter solubility, and change the rate of dissolution in the gut. The melting point of the cocrystal is typically different from either parent compound and depends on the specific molecular pairing. Aspirin–pyrazinamide eutectic systems, for example, have been characterized thermally as part of ongoing research into combination dosage forms.3PubMed Central. Thermodynamic and Structural Characterization of a Mechanochemically Synthesized Pyrazinamide–Acetylsalicylic–Acid Eutectic Mixture
For the everyday user, none of this changes what your aspirin tablet does in your body. But it illustrates why “the melting point of aspirin” is not a single fixed number etched in nature. The answer always comes with a footnote about crystal form, particle size, purity, and what the aspirin is mixed with.
Why Melting Point Still Matters in a World of Advanced Analytics
You might wonder why anyone still cares about the melting point of a compound discovered over a century ago. In pharmaceutical manufacturing, melting behavior feeds directly into decisions about how tablets are made. Granulation, a common step where powders are turned into clumps that flow smoothly into tablet presses, sometimes involves temperatures high enough to soften or partially melt aspirin, especially if friction from compression adds heat. If the aspirin in a formulation begins to degrade at or near its melting point, the process window is narrow and has to be controlled carefully.
Melting point is also one of the simplest ways to authenticate a raw material. Counterfeit or adulterated aspirin, a real concern in some markets, often fails the melting range test because it contains fillers that shift or broaden the observed range. A pharmacist or quality-control technician with a basic melting-point apparatus and a thermometer can flag suspect batches in minutes, long before a full chromatographic analysis comes back from the lab.
In research, aspirin’s thermal behavior has become a convenient model system for studying broader questions about how drugs behave when heated: when and why they decompose, how crystal form influences properties, and how nano-sizing or amorphous conversion can be used to improve drug performance. The fact that aspirin decomposes so close to its melting point, and that its glassy form is unusually resistant to crystallization, gives scientists a rich playground for testing theories that apply to the design of newer, more complex pharmaceuticals.